Related Experiment Video
Updated: Aug 23, 2026

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
Published on: February 28, 2021
BRCA1 is required for common-fragile-site stability via its G2/M checkpoint function
Martin F Arlt1, Bo Xu, Sandra G Durkin
1Department of Human Genetics, 4909 Buhl, Box 0618, 1241 E. Catherine Street, University of Michigan, Ann Arbor, MI 48109-0618, USA.
Abstract:
Common fragile sites are loci that form chromosome gaps or breaks when DNA synthesis is partially inhibited. Fragile sites are prone to deletions, translocations, and other rearrangements that can cause the inactivation of associated tumor suppressor genes in cancer cells. It was previously shown that ATR is critical to fragile-site stability and that ATR-deficient cells have greatly elevated fragile-site expression (A. M. Casper, P. Nghiem, M. F. Arlt, and T. W. Glover, Cell 111:779-789, 2002). Here we demonstrate that mouse and human cells deficient for BRCA1, due to mutation or knockdown by RNA interference, also have elevated fragile-site expression. We further show that BRCA1 functions in the induction of the G(2)/M checkpoint after aphidicolin-induced replication stalling and that this checkpoint function is involved in fragile-site stability. These data indicate that BRCA1 is important in fragile-site stability and that fragile sites are recognized by the G(2)/M checkpoint pathway, in which BRCA1 plays a key role. Furthermore, they suggest that mutations in BRCA1 or interacting proteins could lead to rearrangements at fragile sites in cancer cells.
Insights
BRCA1 deficiency elevates fragile site expression, similar to ATR deficiency. BRCA1 is crucial for the G(2)/M checkpoint, which stabilizes fragile sites during DNA replication stress, implicating BRCA1 in cancer-related chromosomal rearrangements.
Area of Science:
- Genetics
- Molecular Biology
- Cancer Research
Background:
- Common fragile sites are genomic regions susceptible to breaks during DNA replication stress.
- These sites are implicated in cancer development due to potential gene inactivation.
- ATR is known to be critical for fragile site stability.
Purpose of the Study:
- To investigate the role of BRCA1 in fragile site stability.
- To determine if BRCA1 deficiency affects fragile site expression.
- To elucidate the mechanism by which BRCA1 influences fragile sites.
Main Methods:
- Utilized mouse and human cell lines with BRCA1 mutations or RNA interference (knockdown).
- Assessed fragile site expression under conditions of replication stress (aphidicolin treatment).
- Examined the G(2)/M cell cycle checkpoint function in BRCA1-deficient cells.
Main Results:
- BRCA1-deficient cells exhibit significantly elevated fragile site expression.
- BRCA1 is essential for inducing the G(2)/M checkpoint following replication stalling.
- The G(2)/M checkpoint function mediated by BRCA1 is critical for maintaining fragile site stability.
Conclusions:
- BRCA1 plays a key role in maintaining fragile site stability.
- Fragile sites are recognized by the G(2)/M checkpoint pathway, where BRCA1 is a crucial component.
- BRCA1 mutations may contribute to chromosomal rearrangements at fragile sites in cancer cells.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Restarting Stalled Replication Forks
Negative Regulator Molecules
Homologous Recombination
Long-patch Base Excision Repair

